These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1488 related items for PubMed ID: 26186552

  • 1. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, Shan F, Meng Y, Yuan Z.
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA.
    Stem Cell Res Ther; 2017 Apr 26; 8(1):102. PubMed ID: 28446235
    [Abstract] [Full Text] [Related]

  • 3. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord.
    Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW.
    Stem Cells Dev; 2010 Dec 26; 19(12):1895-910. PubMed ID: 20367285
    [Abstract] [Full Text] [Related]

  • 4. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
    Donders R, Bogie JFJ, Ravanidis S, Gervois P, Vanheusden M, Marée R, Schrynemackers M, Smeets HJM, Pinxteren J, Gijbels K, Walbers S, Mays RW, Deans R, Van Den Bosch L, Stinissen P, Lambrichts I, Gyselaers W, Hellings N.
    Stem Cells Dev; 2018 Jan 15; 27(2):65-84. PubMed ID: 29267140
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor.
    Najar M, Raicevic G, Boufker HI, Fayyad-Kazan H, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L.
    Tissue Eng Part A; 2010 Nov 15; 16(11):3537-46. PubMed ID: 20597819
    [Abstract] [Full Text] [Related]

  • 7. Immunological properties of extraembryonic human mesenchymal stromal cells derived from gestational tissue.
    Stubbendorff M, Deuse T, Hua X, Phan TT, Bieback K, Atkinson K, Eiermann TH, Velden J, Schröder C, Reichenspurner H, Robbins RC, Volk HD, Schrepfer S.
    Stem Cells Dev; 2013 Oct 01; 22(19):2619-29. PubMed ID: 23711207
    [Abstract] [Full Text] [Related]

  • 8. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.
    Remacha AR, Barrachina L, Álvarez-Arguedas S, Ranera B, Romero A, Vázquez FJ, Zaragoza P, Yañez R, Martín-Burriel I, Rodellar C.
    Vet Immunol Immunopathol; 2015 Jun 15; 165(3-4):107-18. PubMed ID: 25977164
    [Abstract] [Full Text] [Related]

  • 9. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
    Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, Eom Y, Lee JE, Kim YJ, Yang SK, Jung HL, Sung KW, Kim CW, Koo HH.
    Cell Immunol; 2009 Jun 15; 259(2):150-6. PubMed ID: 19608159
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.
    Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y.
    Int J Mol Med; 2014 Sep 15; 34(3):695-704. PubMed ID: 24970492
    [Abstract] [Full Text] [Related]

  • 11. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL, Sun G, McDonald C, Layton D, Moussa L, Emerson-Webber A, Veron N, Siatskas C, Herszfeld D, Price J, Bernard CC.
    Cell Transplant; 2013 Sep 15; 22(8):1409-25. PubMed ID: 23057962
    [Abstract] [Full Text] [Related]

  • 12. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells.
    Nekanti U, Rao VB, Bahirvani AG, Jan M, Totey S, Ta M.
    Stem Cells Dev; 2010 Jan 15; 19(1):117-30. PubMed ID: 19619003
    [Abstract] [Full Text] [Related]

  • 13. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
    He H, Nagamura-Inoue T, Tsunoda H, Yuzawa M, Yamamoto Y, Yorozu P, Agata H, Tojo A.
    Tissue Eng Part A; 2014 Apr 15; 20(7-8):1314-24. PubMed ID: 24279891
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
    Shi Q, Gao J, Jiang Y, Sun B, Lu W, Su M, Xu Y, Yang X, Zhang Y.
    Stem Cell Res Ther; 2017 Nov 02; 8(1):246. PubMed ID: 29096715
    [Abstract] [Full Text] [Related]

  • 15. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J, Blanco B, Yáñez R, Vázquez M, Herrero Sánchez C, Fernández-García M, Rodríguez Serrano C, Pescador D, Blanco JF, Hernando-Rodríguez M, Sánchez-Guijo F, Lamana ML, Segovia JC, Vicente Á, Del Cañizo C, Zapata AG.
    Cytotherapy; 2016 Oct 02; 18(10):1297-311. PubMed ID: 27637760
    [Abstract] [Full Text] [Related]

  • 16. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.
    Saeidi M, Masoud A, Shakiba Y, Hadjati J, Mohyeddin Bonab M, Nicknam MH, Latifpour M, Nikbin B.
    Iran J Allergy Asthma Immunol; 2013 Mar 02; 12(1):37-49. PubMed ID: 23454777
    [Abstract] [Full Text] [Related]

  • 17. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
    Najar M, Raicevic G, Jebbawi F, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L.
    Immunol Lett; 2012 Aug 30; 146(1-2):50-6. PubMed ID: 22575528
    [Abstract] [Full Text] [Related]

  • 18. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS, Noh MY, Oh KW, Cho KA, Kang BY, Kim KS, Kim YS, Kim SH.
    J Neurochem; 2014 Oct 30; 131(2):206-18. PubMed ID: 24995608
    [Abstract] [Full Text] [Related]

  • 19. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
    Tantrawatpan C, Manochantr S, Kheolamai P, U-Pratya Y, Supokawej A, Issaragrisil S.
    J Med Assoc Thai; 2013 Sep 30; 96(9):1208-17. PubMed ID: 24163998
    [Abstract] [Full Text] [Related]

  • 20. Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton's Jelly.
    Shin S, Lee J, Kwon Y, Park KS, Jeong JH, Choi SJ, Bang SI, Chang JW, Lee C.
    Int J Mol Sci; 2021 Jan 15; 22(2):. PubMed ID: 33467726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.